BioCryst Pharmaceuticals | BCRX - إيرادات الفوائد





إيرادات الفوائد تغيير تاريخ
Alnylam Pharmaceuticals USD 28.68M 1.19M 2025-09
BioCryst Pharmaceuticals USD -0.13 3.59M 2024-12
Chugai Pharma JPY 480M 465M 2024-06
Daiichi Sankyo JPY 9.96B 230M 2024-03
DBV Technologies USD -0.32 0.02 2024-09
Gilead Sciences USD 88M 15M 2025-09
GlaxoSmithKline GBP 26M 24M 2025-09
Glaxosmithkline GBP 26M 24M 2025-09
Incyte USD 30.75M 3.97M 2025-12
Ionis Pharmaceuticals USD -0.66 0.29 2024-12
Karyopharm Therapeutics USD -0.15 0.11 2024-12
Novavax USD 303K 27K 2021-12
Regeneron Pharmaceuticals USD 175.1M 300K 2025-09
Sarepta Therapeutics USD 8.38M 1.24M 2025-09
Ultragenyx Pharmaceutical USD 5.86M 69K 2025-09
Vertex Pharmaceuticals USD 125.7M 3.3M 2025-09